Printable Copy |
Sub-Saharan Africa defies generalization. Many islands and archipelagos have made striking progress against malaria. In central Africa, with the exception of Rwanda, progress is scanty or poorly documented. Everywhere, the need for better disease reporting and modern case finding (through RDTs, notably) is evident.
This article, with maps and tables, is best viewed at
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(10)70096-7/fulltext
Good reading.
BD
The Lancet Infectious Diseases, Volume 10, Issue 8,
Pages 545 - 555, August 2010
Changes in the burden of malaria in sub-Saharan Africa
Original Text
Wendy Prudhomme O'Meara, Judith Nekesa Mangeni, Rick Steketee, Prof Brian Greenwood
Summary
The burden of malaria in countries in sub-Saharan Africa has declined with scaling up of prevention, diagnosis, and treatment. To assess the contribution of specific malaria interventions and other general factors in bringing about these changes, we reviewed studies that have reported recent changes in the incidence or prevalence of malaria in sub-Saharan Africa.
Malaria control in southern Africa (South Africa, Mozambique, and Swaziland) began in the 1980s and has shown substantial, lasting declines linked to scale-up of specific interventions. In The Horn of Africa, Ethiopia and Eritrea have also experienced substantial decreases in the burden of malaria linked to the introduction of malaria control measures. Substantial increases in funding for malaria control and the procurement and distribution of effective means for prevention and treatment are associated with falls in malaria burden. In central Africa, little progress has been documented, possibly because of publication bias. In some countries a decline in malaria incidence began several years before scale-up of malaria control. In other countries, the change from a failing drug (chloroquine) to a more effective drug (sulphadoxine plus pyrimethamine or an artemisinin combination) led to immediate improvements; in others malaria reduction seemed to be associated with the scale-up of insecticide-treated bednets and indoor residual spraying.
Introduction
After a period of neglect, the urgent need to control malaria has once again engaged the attention of the international health community. Control of malaria is now on the political agenda of several of the world's wealthiest countries and funds have become available from the Global Fund to Fight
AIDS, Tuberculosis and Malaria, The US President's Malaria Initiative, the
World Bank, and bilateral donors on a scale not seen since the first
attempted malaria eradication campaign in the 1950s and 1960s. The global
fight against malaria is now being coordinated by the Roll Back Malaria
Partnership , and major donor foundations,
such as the Bill and Melinda Gates Foundation, have greatly increased
financial support for malaria research. When compared with the low coverage
of malaria control measures in 1999—2001,1these investments have resulted in an increase in global production,
procurement, distribution, and use of insecticide-treated bednets (ITNs).
Global production more than tripled from 30 million in 2004 to 100 million
in 2008. UNICEF procurement increased roughly 20-fold between 2000 and 2005
and has been stable since.2,
3Ownership and use of ITNs within households, as measured by the number of
children under 5 years of age reported to have used an ITN the previous
night, increased by three to ten times between 2000 and 2008 in many African
countries.2There has also been an increase of about 25 times in the global procurement
of artemisinin combination therapies (ACTs) in the past 5 years.2,
3
A renewed focus on elimination (cessation of local transmission of malaria
within a defined geographical region) and eradication (global disappearance
of one or more species of malaria parasite)4has spurred several new initiatives, such as the Malaria
Elimination Group , focusing on
practical components of malaria elimination and the Malaria Eradication
Research Agenda group setting the research
agenda needed to support elimination and eradication.
This drive towards elimination has been encouraged by reports from several
malaria endemic areas of declines in incidence of clinical cases and deaths.
These changes have coincided with scale-up of effective prevention with ITNs
and the use of more effective treatments for malaria in endemic areas. In
some areas, additional vector-control measures, including indoor residual
spraying and larval control have been deployed. The situation in Africa as a
whole and how specific interventions have contributed to success stories is
unclear. Therefore, we reviewed the relation between reported changes in the
incidence or prevalence of malaria and the introduction or scale-up of
specific interventions in several countries in sub-Saharan Africa. In this
Review, we aim to identify common patterns and investigate whether factors
other than these specific interventions might have contributed to the
changes in malaria burden that have been reported.
13 key papers, which describe recent changes in malaria morbidity in
sub-Saharan Africa were identified by consultation with experts. These
papers were used as a guideline for a search for similar or related
published studies. For each article reported we noted the: country, region,
study period, population size, local endemicity, control measures and other
factors independent of the study that might have affected transmission,
rainfall data (if available), the type of data (ie, outpatient numbers,
inpatient numbers, malaria mortality, prevalence), whether cases were slide
confirmed, and the percentage change and the years of change for each type
of data reported. The total number of malaria outpatients or inpatients for
each reported year and the total number of deaths were also noted, when the
information was available.
Changing malaria burden in sub-Saharan Africa
We identified studies that recorded trends in malaria indicators over time
from countries in sub-Saharan Africa (figure 1,
table).
Most reports describe a recent decline in the incidence of malaria, the rest
report little or no change.
Figure 1 Full-size image(47K)
Distribution of reports included in the Review
TableTable image
Reports of changes in the pattern of malaria in sub—Saharan African
1999—2009.
The Horn of Africa
Reports from Ethiopia have documented declines in malaria morbidity across
the country.5,
6Surveillance from 2000—07 demonstrated a 70% reduction in both outpatients
with slide-confirmed malaria and children less than 5 years old admitted to
hospital for malaria. Outpatient malaria cases were already declining at the
beginning of the surveillance period, before mass-distribution of ITNs and
treatment with ACTs were introduced in late 2005. The decline in patients
admitted to hospital with malaria was slower than the decline in outpatient
malaria. The largest drop in morbidity occurred at the same time as in other
parts of east Africa—2005—06.
The epidemiology of malaria in Ethiopia differs from that in most of
sub-Saharan Africa. Transmission is heterogeneous and generally lower than
in other countries, and Plasmodium vivax is endemic and causes up to 40%
of clinical cases.5A small study showed a decline in the overall incidence of malaria
accompanied by a shift from predominantly P vivax cases to 73% Plasmodium
falciparum cases.7
Reports from Eritrea paint a similar picture. Between 1998 and 2004,
substantial reductions in routinely reported clinical malaria cases were
described following a scale-up of control measures.8—10There was a reduction in both the incidence of presumptive malaria in
outpatient facilities (83% decline) and in the case fatality of malaria
admissions (25% decline overall, but trend inconsistent over the time
period). The largest decline in malaria cases was seen between 1998 and
2000. ITN ownership was 80% in 2004, but only 50% of households, when
surveyed, reported anyone having slept under an ITN the night before. It is
very likely that the massive scale-up of ITNs, indoor residual spraying,
community-based management of fevers, and environmental management of
mosquito breeding sites all contributed to these results. However, the
incidence of malaria was already declining at the beginning of the
surveillance period, before these interventions were introduced. Graves and
colleagues8showed that malaria cases increased between 1996 and 1998 before beginning
to decline in 1999; although the increase in cases could have been due to
improved reporting practices. A time-series analysis by Nyarango and
co-workers10showed that the scale-up of ITNs and indoor residual spraying was associated
with a reduction in malaria cases but not with a decline in case fatality,
whereas an expansion of community health-worker training was temporally
associated with the decline in case fatality but not with the reduction in
malaria cases.
East Africa
Many reports from east Africa have recorded substantial reductions in
malaria transmission and morbidity in the region. In the coastal area of
Kenya, paediatric malaria admissions declined by as much as 75% between 2003
and 2007.11,
12Since the mid-1990s, parasite prevalence in the Kilifi district has declined
progressively from 35% to less than 1%. Prevalence declined by 30% before
any change in the incidence of malaria admissions was recorded. Although ITN
use has increased concurrently with the decline in paediatric admissions,12
the prevalence of malaria infection declined from 35% to 10% before ITN
coverage reached 25%, and before the introduction of ACTs.11
In a district in central Kenya, the proportion of malaria outpatient visits
declined from 40% in 2000 to 0% by the end of 2006, with the largest decline
between 2003 and 2005.13Coverage with ITNs in the area is estimated to be 65%, substantially higher
than that reported on the coast, and 35% of households reported use of some
mosquito reduction method, such as environmental management or repellents.
This study is one of the few in which entomological data were collected
concurrently with longitudinal morbidity data. The entomological inoculation
rate was estimated to be very low: 0—0·03 infectious bites per person per
year in the hospital catchment area.
In western Kenya, malaria transmission in the lowland areas around Lake
Victoria has historically been very high, with entomological inoculation
rates estimated to be as high as 250 infectious bites per person per year.
14,
15Between 2003 and 2007, demographic surveillance revealed a 42% reduction in
all-cause mortality among children less than 5 years of age.16A 16% decline in malaria-specific mortality was estimated using verbal
autopsy methods.16Verbal autopsy methods have low specificity,
17and malaria-specific mortality likely declined substantially more than was
suggested by verbal autopsy.
Data compiled from paediatric inpatient records of 17 hospitals across Kenya
(including hospitals on the coast and in western Kenya) showed different
temporal trends in malaria admissions between 1999 and 2008.18Only four hospitals had clear, substantial declines in malaria admissions.
Six other sites had small or unstable declines. Only six of ten sites that
reported reductions in malaria admissions also reported reductions in
all-cause admissions, which would suggest a true decline in malaria
admissions, rather than a re-classification because of changing diagnostic
practices. In seven other sites, malaria admissions remained stable or
increased. Across all sites together the number of paediatric malaria
admissions decreased by 49%. However, this average masks the heterogeneity
of the effect of nationwide malaria control.
In Rwanda, data from 20 facilities representing every district in the
country showed a decline of more than 50% between 2005 and 2007 in both
inpatient and outpatient slide-confirmed malaria cases.6Before 2005, the number of cases had been increasing annually, but began to
decline shortly before or at the same time as mass distribution of
long-lasting insecticidal bednets and the use of ACTs in 2006—07.
In neighbouring Burundi, routine health-facility reporting from the Karuzi
province showed an epidemic peak of clinically diagnosed malaria in 2001,
against a background of low but stable monthly incidence of cases.19Between 2002 and 2005, annual indoor residual spraying interventions in the
province had only a small effect on parasite prevalence.20Prevalence in children less than 9 years old declined from 64% to 40%, but
the latter figure was not always significantly different from the control
group over the 3 years of intervention. No additive benefit of bednets could
be detected, and indoor residual spraying in the lowland areas did not
reduce prevalence of infection in adjacent highlands.20
In contrast to the largely encouraging reports from Kenya and Rwanda, data
from a highland and a lowland area in western Uganda showed steadily
increasing numbers of malaria cases and deaths in district hospitals from
1991 to 2000, with a two-fold to four-fold overall increase in the number of
children admitted to hospital with the disease.21A slight decline in the proportion of positive blood films was seen in a
single facility in an area of moderate transmission in Uganda after one
round of indoor residual spraying in 2007.2214 months after indoor residual spraying, the proportion of blood films that
tested positive began to increase, suggesting that trends are easily
reversed if control measures are not sustained.
In Muheza district, Tanzania, the number of malaria cases increased between
1994 and 2002, with prevalence among children remaining consistently above
80%.23However, the incidence of malaria has recently declined substantially in
some parts of northeastern Tanzania. In the same district, the incidence of
malaria in children fell rapidly during the early 2000s, reaching such a low
level that a trial of intermittent preventive treatment in infants had to be
stopped in 2005 as there were not enough cases.24In the neighbouring Korogwe district, the prevalence of malaria parasitaemia
among febrile patients fell substantially between 2003 and 2006 from 78% to
24% in lowland areas and from 25% to 7% in highland areas.25These changes were detected by community health workers who treated fevers
presumptively for malaria but collected blood films at the time of
treatment. Improved access to effective treatment through the community
programme probably contributed to the decline. At least four of eight
hospitals included in a review of admission data in southwest Tanzania
showed higher numbers of malaria admissions between 1995 and 2000 than in
the preceding 10 years; the number of malaria admissions declined at only
one of the hospitals.26The current situation in these areas has not been reported. Recent
entomological data from the Kilombero Valley in Tanzania, an area with one
of the highest rates of transmission in the world, reported a 60—70% lower
entomological inoculation rate than previously recorded;27although the effect of that decline on clinical malaria is unknown.
In highland areas of east Africa, where malaria transmission is unstable and
prone to epidemics, stable transmission has been reported in areas that have
historically been thought to have only periodic epidemic transmission.28In these areas of stable transmission, adults have functional immunity to
malaria and the age ratio of cases in children to adults is greater than
one. The number of cases in three highland hospitals in western Kenya
gradually increased up to the year 2000, although transmission remains
strongly seasonal. More recent data from a few villages in highland Kenya
show success of government efforts to control malaria. Malaria incidence
declined from roughly 100 cases per 1000 people per year in 2003 to no cases
at all in 2008.29Because ITN coverage was less than 25%, this success is probably
attributable to sequential rounds of indoor residual spraying covering
70—95% of households. By contrast, data from two highland sites in Uganda
show slight increases in slide-confirmed cases from 2002 to 2006.30Anecdotal evidence from Burundi suggests that malaria transmission is
occurring at higher altitudes than ever before.31
Central Africa
Because of a lack of research initiatives and poor infrastructure to support
routine case reporting data from central Africa are sparse. The limited data
available show little change in the malaria burden from historical levels.
In Brazzaville, Congo, the percentage of paediatric hospital admissions due
to malaria (30%) did not change between 1989 and 2001.32Data from eight malaria reference laboratories in eastern Sudan showed a
slight decline in the proportion of positive smears between 1998 and 2002,
but this decline followed a period of increased malaria infection during
several years of heavy rains33and brought the proportion back to the levels noted before the heavy rains.
Two small cross-sectional studies in Cameroon in 2000 and 2004 showed a
slight decline in parasite prevalence among asymptomatic children, but no
change in prevalence among febrile children.34
Southern Africa
In South Africa, sustained malaria control over many decades has succeeded
in stopping transmission throughout most of the country, with the exception
of the northeastern border regions adjacent to Mozambique and Swaziland.3530 years of passive and active detection of slide-confirmed malaria cases
from the province of KwaZulu Natal give a comprehensive, long-term picture
of the effect of changing control strategies, climatic factors, and other
variables that have influenced the incidence of malaria over time. Parasites
resistant to both chloroquine and sulphadoxine plus pyrimethamine, a rising
prevalence of HIV, the emergence of mosquitoes resistant to pyrethroid
insecticides used for indoor residual spraying, and increasing cases of
imported malaria contributed to a five-fold increase in malaria cases in the
province between the mid-1990s and 2001.36Climatic factors were shown to explain seasonality and short-term trends,
but not long-term trends.37In 2001, DDT was reintroduced for indoor residual spraying and cases began
to decline almost immediately. Data from sentinel facilities showed an 89%
decline in malaria admissions and deaths and an 85% decline in outpatient
malaria cases in the year after reintroduction of DDT. Replacement of
failing sulphadoxine plus pyrimethamine with an ACT might also have
contributed to the decline. By 2003, cases had declined by 99% from their
peak in 2000.38
A related report from the bordering regions of Mozambique, Swaziland, and
South Africa highlights the importance of coordinated regional control.39Although indoor residual spraying has been ongoing in Swaziland since 1981,
malaria remained a significant public health problem. In 2001, when South
Africa reintroduced DDT, Mozambique initiated indoor residual spraying
programmes in the border regions. The prevalence of malaria declined
substantially in regions of Mozambique that were part of the indoor residual
spraying programmes, although it dropped below 20% in only one of five spray
zones. Slide-confirmed inpatient and outpatient malaria cases at a district
hospital in the indoor residual spraying areas showed no consistent trend
between 2003 and 2005, indicating that the incidence of symptomatic cases
might have stabilised.40,
41The incidence of cases reported in the two bordering South African provinces
declined by 80—95% in 4 years. Despite no changes in malaria control
interventions, cases in Swaziland showed a similar decline of 95%,
presumably as a result of activities in neighbouring regions.
On the western side of Swaziland, the province of Limpopo in South Africa
also reported reductions in the incidence of malaria cases. Routine
slide-confirmed case reporting data from 1998 to 2007 showed significant
declines in cases from 2001 until the end of the reporting interval.42As in KwaZulu Natal, the main malaria control intervention in Limpopo is
indoor residual spraying, with DDT being reintroduced in 2001. ACTs were
deployed in 2004.
The Zambian National Malaria Control Programme has achieved substantial
success in scaling up the use of ITNs, indoor residual spraying, and
intermittent preventive treatment in pregnancy with sulphadoxine plus
pyrimethamine. ITN ownership increased substantially from 22% in 2004, to
38% in 2006, and 62% in 2008.43,
44Between 2006 and 2008, paediatric malaria parasite prevelance declined by
53% and moderate to severe anaemia by 69%.44A report from a single outpatient facility showed a remarkable decline in
the proportion of febrile cases with malaria, from 40% in 2003 and 84% in
2004 to less than 1% in 2008.45
In Zimbabwe, data are less encouraging. Reductions in donor funding and
national support are likely to account for the increasing morbidity and
mortality from suspected malaria reported between 2001 and 2003.46
West Africa
Compelling evidence for a dramatic decline in malaria transmission comes
from The Gambia where surveillance at five health facilities across the
country showed a 50—85% decline in the prevalence of slide-confirmed malaria
among outpatients and a 25—90% decline in malaria-related hospital
admissions.47The trend persisted over 7 years with an apparent contribution from ITN
coverage, which increased three-fold to 49% over the surveillance period.
The observed reductions were before the introduction of ACTs. The number of
outpatient cases declined before the number of inpatient cases did.
Apart from The Gambia, other evidence from west Africa comes from a handful
of individual hospitals or villages. An urban hospital in Libreville, Gabon
48reported an 80% decline in the number of children with positive blood smears
in the inpatient and outpatient services. The decline began in 2003 and
persisted until the end of the surveillance period in 2008. The decline
pre-dated both the introduction of ACTs in 2006 and ITN distribution in
2005, the coverage of the latter reaching 50% in 2008. Data from one village
in Senegal showed an increase in the incidence of slide-confirmed malaria
between 1998 and 2001 followed by a slight decline of 20% in 2002, although
the incidence in 2002 was still higher than in 1998.49In Niakhar, Senegal, presumptive malaria (facility surveillance) and malaria
mortality (community-based verbal autopsy) fluctuated considerably between
1992 and 2004, but no consistent trends were observed.50
A study from a hospital in Nigeria reported severe malaria accounting for a
steadily increasing proportion of hospital admissions between 2000 and 2005,
with nearly 13% of patients admitted having either severe malarial anaemia
or cerebral malaria by the end of the study.51Reports from Burkina Faso mention a three-fold increase in malaria cases at
health facilities between 2000 and 2007 in at least one district, despite
increasing bednet coverage.52
There was only one report that discussed the effect of agricultural
practices on the risk of malaria infection.53Malaria indicators in two villages in Côte d'Ivoire with similar, intense
transmission but different agriculture practices were compared. Both the
number of malaria cases and the entomological inoculation rate temporarily
declined in one village with irrigated rice farming when irrigation was
interrupted for a season. During the same season, the village without
irrigated rice farming had a very slight decline in presumptive malaria
cases, despite an increase in entomological inoculation rate from 230 to 570
infective bite per person per year.
African islands
Some of the most remarkable successes have been reported from islands,
including Bioko (part of Equatorial Guinea), Zanzibar, and Sao Tome and
Principe. On Zanzibar, an 87% decline in parasite prevalence was mirrored by
a 75% decline in clinically diagnosed malaria outpatient visits and hospital
admissions.54Review of monthly clinical cases of malaria in children less than 5 years of
age showed that the downward trend began about 1 year after the introduction
of ACTs, and before the widespread distribution of ITNs. The number of cases
dropped from more than 1500 per month to fewer than 100 per month before the
initiation of ITN distribution campaigns. Changes in diagnostic practices
might have had an effect on these figures. The timing of the decline (2005
to 2006) is similar to that of other reports from the region.
The Bioko Island Malaria Control Project was launched in 2003 and combined
bi-annual indoor residual spraying programmes with the introduction of ACTs
and scale-up of the use of intermittent preventive treatment in pregnancy.
55,
56Distribution of long-lasting insecticidal bednets started much later, in
2007. After 4 years of intensive vector control and improved case
management, sporozoite rates were reduced by ten times, leading to a decline
in cross-sectional prevalence of malaria parasitaemia in children from 42%
to 18%, and a 50% reduction in the prevalence of fever. A remarkable 70%
reduction in all-cause mortality in children age less than 5 years was
reported in this intervention time interval.57
On Sao Tome, surveillance data between 1995 and 2007 showed malaria
outpatient consultations and hospital admissions declined by 80—90% in both
adults and children after introduction of indoor residual spraying, ACTs,
and long-lasting insecticidal bednets in 2004.58Indoor residual spraying on Sao Tome resulted in a reduction of paediatric
parasite prevalence from 30% to less than 1%, a greater reduction than
indoor residual spraying programmes in Burundi, where prevalence fell from
50% to 40%, and in Mozambique, where prevalence fell from 65% to 20%.59
Discussion
The burden of malaria has declined substantially in several areas of
sub-Saharan Africa, particularly in the past 3—5 years, coinciding with
expanding coverage of malaria prevention and treatment in many countries (figure
2).
Country-wide surveillance in Ethiopia and Eritrea reveals a 70% decline in
malaria morbidity, with similar changes documented in parts of Kenya, The
Gambia, Rwanda, and Zambia. Malaria control on islands has been remarkably
successful, even though the approaches used have been diverse. However,
other reports describe a static or deteriorating situation in some
locations. Malaria transmission may be increasing in the highland areas of
east Africa, perhaps as a result of environmental conditions that facilitate
transmission. Several countries in west and central Africa have not yet had
any significant reductions in malaria incidence. The situation in large
parts of Africa is unknown.
Figure 2 Full-size image(129K)
Changes in the malaria burden in different regions of sub-Saharan Africa
Malaria “burden” defined as worsening (red) if malaria indicators increased
for 2 years consecutively, unchanged (blue) if malaria indicators decreased
for at least 2 years consecutively, or improving (green) if they did not
change in either direction during the study. Malaria indicators used were
the incidence of inpatient or outpatient cases of malaria, deaths from
malaria in children, or the prevalence of malaria infection.
The success stories include countries across the spectrum of transmission
intensity. Progress may have been predominantly made in countries with low
to moderate endemicity, but these countries might have started malaria
control efforts at an early date. In southern Africa (South Africa,
Swaziland, and parts of Mozambique), aggressive control started in the 1970s
and 1980s and is ongoing. In this case, successful control was accelerated
by adopting a regional strategy rather than individual country approaches.
Although expanded control efforts began more recently in Eritrea and
Ethiopia, they have seen early and durable declines. Unfortunately, data are
not available for large parts of sub-Saharan Africa, including countries
with high and often seasonally intense transmission.
Many reports attribute decreases in malaria morbidity to specific
interventions, although the causal link between the decline and the
intervention is more convincing in some cases than in others (figure 3).
In several reports, the decline began before the specific intervention was
deployed, or the decline was already underway at the beginning of the study
period, suggesting that factors not investigated contributed to the decline.
This is highlighted in the two reports from the coast of Kenya, one of which
shows an association between ITN distribution and a decline in admissions of
children with malaria to hospital whereas the other shows substantial
changes in prevalence of malaria infection before the decline in admissions
and the distribution of ITNs.11,
12Similarly, in The Gambia and Zanzibar, the decline in malaria began before
ITNs were rolled out. In Eritrea and Ethiopia, a substantial outbreak
occurred from late 2002 to 2005,60thus declines in malaria incidence back to historical levels were already
underway as interventions were introduced in 2005 and 2006. In other
reports, the temporal association with the introduction of specific
interventions is compelling, particularly in the data from the northern
provinces of South Africa and Bioko Island.
Figure 3 Full-size image(96K)
Changes in malaria indicators over time relative to the introduction or
scaling up of control measures in selected countries
(A) Number of malaria hospital admissions in Zanzibar.46(B) Number of malaria hospital admissions in Ethiopia.
6(C) Proportion of hospital admissions due to malaria in Fajara, The Gambia.
40(D) Incidence of paediatric malaria hospital admissions (hospitalisations
per 1000 children in the hospital catchment area) in Kilifi, Kenya.11(E) Number of malaria cases in Limpopo, South Africa.
36(F) Number of malaria cases in Sao Tome and Principe.
48(G) All cause mortality in children less than 5 years of age per 1000 births
in Bioko Island, Equitorial Guinea.47ACT=artemisinin combination therapies. LLITNs=long-lasting
insecticide-treated bednets. ITNs=insecticide-treated bednets.
CQ+SP=chloroquine with sulfadoxine plus pyrimethamine. IRS=indoor residual
spraying.
Indoor residual spraying, ITNs, and ACTs reduce mortality and morbidity from
malaria when deployed under controlled conditions. Indoor residual spraying
probably had a key role in achieving successful malaria control in South
Africa and on Bioko and Sao Tome islands but its effect seems to have been
smaller in other places. There is strong evidence that ITNs can provide a
substantial degree of protection against mortality and morbidity from
malaria,61especially when used by a high proportion of the population. Widespread
deployment of ACTs, which are partly gametocytocidal, would be expected to
have an effect on transmission of malaria in communities where a high
proportion of infected individuals have symptoms and seek treatment.62,
63Thus, for example, introduction of ACTs might have contributed to the
success of malaria control in South Africa.38ACTs would not be expected to have a major effect on malaria transmission in
communities where only a small proportion of infected individuals are sick
and seek treatment. In Zanzibar, the fall in malaria incidence before the
introduction of ITNs or indoor residual spraying that followed the
introduction of ACTs was, therefore, suprising.54This finding could be explained by the concurrent scale-up of malaria
diagnostics which reduced the number of presumptive cases reported, or by
the high incidence of chloroquine treatment failure at the time of the
switch to ACTs. Similarly, in The Gambia and Kilifi district, Kenya, the
fall in malaria incidence began at roughly the same time as first-line
treatment with chloroquine was changed to treatment with sulphadoxine plus
pyrimethamine or sulphadoxine plus pyrimethamine plus chloroquine.11,
47This change replaced an ineffective drug (chloroquine) with an effective one
(sulphadoxine plus pyrimethamine) and it provided a single-dose treatment
(most likely improving cure rates) and a period of chemoprevention against
new infections that persists for several weeks.64The chemopreventive effect of sulphadoxine-pyrimethamine might be especially
important in areas such as The Gambia where malaria transmission is
restricted to a few months of the year.
On the basis of current models of malaria transmission, we would not expect
partial coverage with ITNs and the introduction of ACTs to result in the
substantial changes in malaria incidence seen in areas with moderate
transmission. Alternative explanations for these changes should be
considered. Previous experience in Europe and North America has shown that
malaria declines as social conditions and education improve. However, these
changes (eg, improvements in house construction) are likely to be gradual
and cannot account for the sudden changes seen during the past few years,
although they might have contributed. Malaria transmission is strongly
affected by climate. However, climate has been carefully monitored in
several case studies, and although there have been fluctuations from year to
year, no overall pattern emerges that can explain the remarkable reductions
in malaria cases in some countries. A highly speculative explanation for the
reductions is a change in the parasite or its mosquito vector that has
reduced transmissibility of the infection. Both of these are biological
possibilities, but such a change seems unlikely on the opposite sides of the
continent at the same time. Finally, the transmissibility of P falciparummalaria might not be as high as has been previously thought, making it
easier for any transmission blocking intervention directed at either the
parasite (ACTs) or the vector (ITNs or indoor residual spraying) to reduce
transmission.
We must bear in mind the limitations in using published scientific
literature to assess the progress of ongoing malaria control programmes.
Some of the reports in this Review might be biased towards presenting data
that reflect well on the outcome of a control programme (to justify
investments) or even presenting data that suggest the malaria burden is
worsening (to encourage further investment into malaria control);
maintenance of the status quo is unlikely to result in publication in the
scientific literature. For example, three studies from Kenya show exciting
reductions in the burden of malaria, but data from 17 hospitals reveal that
there are many areas where malaria is not declining. Many of the reports we
have reviewed are limited in time and geographic scope, and therefore might
not accurately reflect nation-wide trends. Most of these reports rely on
clinical diagnosis of malaria at a health facility. We cannot account for
the effect of changes in access to care or use of health services on
incidence measured at the facility. More importantly, changes in diagnostic
practices or access to diagnostics over time can greatly affect observed
trends. Despite these limitations, the overall picture that emerges when
these studies are assembled is coherent and encouraging.
Conclusions
Reports from several countries in sub-Saharan Africa show a substantial,
recent decline in the burden of malaria. Similar changes might have occurred
in some other countries, for example Senegal, but these have not been
reported in peer-reviewed publications. In other countries, there has
probably been little change in the malaria burden. Successful control seems
to have been achieved in several different ways, but it has sometimes proved
difficult to link the timing of an apparent decline in the incidence of
malaria with the introduction of a specific intervention. Whether certain
interventions are more likely to have an effect on different outcome
measures cannot be determined, for example, whether scale-up of effective
treatment has a greater effect on burden of clinical malaria than on
prevalence. Although numbers of clinical cases have declined in many areas,
this does not mean that transmission is being interrupted or that these
areas are approaching elimination.
We have restricted our analysis to information presented in peer reviewed
journals and presented at international scientific meetings, and we have
focused on clinical malaria rather than on the prevalence of infection. Many
other relevant datasets likely exist (eg, parasite prevalence data as
presented in the Malaria Atlas Project ), which
would define the changing pattern of malaria in sub-Saharan Africa more
clearly than we have been able to do in this Review. We hope that this
initial attempt to review the changing pattern of malaria in sub-Saharan
Africa and the possible causes will encourage more detailed work in this
important area.
Search strategy and selection criteria
We searched the National Library of Medicine's Medline database with the
Medical Subject Headings “Africa South of the Sahara”,
“Malaria/epidemiology”, “Malaria/mortality”, “Malaria/prevention and
control”, and “Malaria/transmission”, omitting papers that contained the
keywords “Malaria/immunology”. The search was limited by restricting
retrieval to articles published in the past 10 years. Our last search was
done on March 29, 2010. The search identified 1528 publications. Articles
were included if they reported at least 2 years of data on malaria-specific
indicators (clinical or slide diagnosed case numbers, incidence, prevalence,
or malaria-specific mortality) in a population of more than 1000 people.
Cross-sectional studies reporting a single timepoint, those involving only
pregnant women, intervention studies covering 1 year or less of follow-up,
and entomological studies without any clinical or parasitological components
were excluded. Also excluded were studies published in the selected time
frame but which did not report data from the period 1999—2009. The titles
for each citation were screened and 297 were selected for review of their
abstracts. Screening of the abstracts yielded 82 publications for full
review. After reviewing the full texts, 46 studies that fully met the
inclusion criteria were identified.
Contributors
WPO and BG conceived the paper. WPO and JMM developed the data search and
extracted the data. All authors contributed to interpretation of the data,
drafting the paper, and developing the figures.
Conflict of interests
We declare that we have no conflicts of interest.
Acknowledgments
We thank Geoffrey Targett and F Ellis McKenzie for their helpful comments on
the paper.
References
1
Monasch R, Reinisch A, Steketee RW, Korenromp EL, Alnwick D, Bergevin Y. Child
coverage with mosquito nets and malaria treatment from population-based
surveys in african countries: a baseline for monitoring progress in roll
back malaria. Am J Trop Med Hyg 2004; 71: 232-238. PubMed
2 Malaria
and children: progress in intervention coverage. Summary update. New York:
United Nations Children's Fund, 2009.
http://www.unicef.org/health/files/WMD_optimized_reprint.pdf. (accessed June
17, 2010).
3 Malaria
and children: progress in intervention coverage. New York: United Nations
Children's Fund, 2007.
http://www.unicef.org/health/files/Malaria_Oct6_for_web%281%29.pdf. (accessed
June 17, 2010).
4
Roberts L, Enserink M. Malaria: did they really say…eradication?. Science
2007; 318: 1544-1545. CrossRef|
PubMed
5
Yeshiwondim AK, Gopal S, Hailemariam AT, Dengela DO, Patel HP. Spatial
analysis of malaria incidence at the village level in areas with unstable
transmission in Ethiopia. Int J Health Geogr 2009; 8: 5. CrossRef|
PubMed
6
Otten M, Aregawi M, Were W, et al. Initial evidence of reduction of malaria
cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria
prevention and treatment. Malar J 2009; 8: 14. CrossRef|
PubMed
7 Manuel
Ramos J, Reyes F, Tesfamariam A. Change in epidemiology of malaria
infections in a rural area in Ethiopia. J Travel Med 2005; 12: 155-156.
CrossRef | PubMed
8
Graves PM, Osgood DE, Thomson MC, et al. Effectiveness of malaria control
during changing climate conditions in Eritrea, 1998—2003. Trop Med Int
Health 2008; 13: 218-228. CrossRef|
PubMed
9
Mufunda J, Nyarango P, Usman A, et al. Roll back malaria—an African success
story in Eritrea. S Afr Med J 2007; 97: 46-50. PubMed
10
Nyarango PM, Gebremeskel T, Mebrahtu G, et al. A steep decline of malaria
morbidity and mortality trends in Eritrea between 2000 and 2004: the effect
of combination of control methods. Malar J 2006; 5: 33. CrossRef|
PubMed
11
O'Meara WP, Bejon P, Mwangi TW, et al. Effect of a fall in malaria
transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008;
372: 1555-1562. Summary| Full
Text|
PDF(241KB) |
CrossRef|
PubMed
12
Okiro EA, Hay SI, Gikandi PW, et al. The decline in paediatric malaria
admissions on the coast of Kenya. Malar J 2007; 6: 151. CrossRef|
PubMed
13
Okech BA, Mwobobia IK, Kamau A, et al. Use of integrated malaria management
reduces malaria in Kenya. PLoS One 2008; 3: e4050. CrossRef|
PubMed
14
Beier JC, Oster CN, Onyango FK, et al. Plasmodium falciparum incidence
relative to entomological inoculation rates at a site proposed for testing
malaria vaccines in Western Kenya. Am J Trop Med Hyg 1994; 50: 529-536.
PubMed
15
Beier JC, Perkins PV, Onyango FK, et al. Characterization of malaria
transmission by Anopheles (Diptera: Culicidae) in western Kenya in
preparation for malaria vaccine trials. J Med Entomol 1990; 27: 570-577.
PubMed
16Adazu K, Hamel M, Feiken D, et al. Marked decline in childhood mortality in
the Western Kenya DSS: evidence from longitudinal data 2003—2007. American
Society of Tropical Medicine and Hygiene, 57th Annual Meeting; New Orleans,
Louisiana, USA; Dec 7—11, 2008. Abstract #372.
17
Snow RW, Armstrong JRM, Forster D, et al. Childhood deaths in Africa: uses
and limitations of verbal autopsies. Lancet 1992; 340: 351-355. Summary
|
CrossRef | PubMed
18
Okiro EA, Alegana VA, Noor AM, Mutheu JJ, Juma E, Snow RW. Malaria
paediatric hospitalization between 1999 and 2008 across Kenya. BMC Med
2009; 7: 75. CrossRef | PubMed
19
Gomez-Elipe A, Otero A, van Herp M, Aguirre-Jaime A. Forecasting malaria
incidence based on monthly case reports and environmental factors in Karuzi,
Burundi, 1997—2003. Malar J 2007; 6: 129. CrossRef|
PubMed
20
Protopopoff N, Van Bortel W, Marcotty T, et al. Spatial targeted vector
control is able to reduce malaria prevalence in the highlands of Burundi. Am
J Trop Med Hyg 2008; 79: 12-18. PubMed
21
Ndyomugyenyi R, Magnussen P. Trends in malaria-attributable morbidity and
mortality among young children admitted to Ugandan hospitals, for the period
1990—2001. Ann Trop Med Parasitol 2004; 98: 315-327. CrossRef|
PubMed
22
Bukirwa H, Yau V, Kigozi R, et al. Assessing the impact of indoor residual
spraying on malaria morbidity using a sentinel site surveillance system in
Western Uganda. Am J Trop Med Hyg 2009; 81: 611-614. CrossRef|
PubMed
23
Alilio MS, Kitua A, Njunwa K, et al. Malaria control at the district level
in Africa: the case of the muheza district in northeastern Tanzania. Am J
Trop Med Hyg 2004; 71 (suppl 2): 205-213. PubMed
24
Gosling RD, Gesase S, Mosha JF, et al. Protective efficacy and safety of
three antimalarial regimens for intermittent preventive treatment for
malaria in infants: a randomised, double-blind, placebo-controlled trial.
Lancet 2009; 374: 1521-1532. Summary|
Full Text|
PDF(579KB) |
CrossRef|
PubMed
25Lusingu JP, Vestergaard L, Mmbando BP, et al. A declining burden of malaria
in northeastern Tanzania. American Society of Tropical Medicine & Hygiene,
57th Annual Meeting; New Orleans, Louisiana, USA; Dec 7—11, 2008. Abstract
#601.
26
Maegga BT, Cox J, Malley KD. Malaria in the southern highlands of Tanzania:
a review of hospital records. Tanzan Health Res Bull 2005; 7: 125-132.
PubMed
27
Killeen GF, Tami A, Kihonda J, et al. Cost-sharing strategies combining
targeted public subsidies with private-sector delivery achieve high bednet
coverage and reduced malaria transmission in Kilombero Valley, southern
Tanzania. BMC Infect Dis 2007; 7: 121. CrossRef|
PubMed
28
Hay SI, Noor AM, Simba M, et al. Clinical epidemiology of malaria in the
highlands of western Kenya. Emerg Infect Dis 2002; 8: 543-548. PubMed
29
John CC, Riedesel MA, Magak NG, et al. Possible interruption of malaria
transmission, highland Kenya, 2007—2008. Emerg Infect Dis 2009; 15:
1917-1924. PubMed
30
Kristan M, Abeku TA, Beard J, et al. Variations in entomological indices in
relation to weather patterns and malaria incidence in East African
highlands: implications for epidemic prevention and control. Malar J 2008;
7: 231. CrossRef | PubMed
31
Bonora S, De Rosa FG, Boffito M, Di Perri G, Rossati A. Rising temperature
and the malaria epidemic in Burundi. Trends Parasitol 2001; 17: 572-573.
CrossRef | PubMed
32
Mabiala-Babela JR, Samba-Louaka C, Mouko A, Senga P. Morbidity in a
paediatric department (University Hospital of Brazzaville): 12 years later
(1989—2001). Arch Pediatr 2003; 10: 650-652. PubMed
33
Himeidan YE, Hamid EE, Thalib L, Elbashir MI, Adam I. Climatic variables and
transmission of falciparum malaria in New Halfa, eastern Sudan. East
Mediterr Health J 2007; 13: 17-24. PubMed
34
Kimbi HK, Nformi D, Patchong AM, Ndamukong KJ. Influence of urbanisation on
asymptomatic malaria in school children in Molyko, South West Cameroon. East
Afr Med J 2006; 83: 602-609. PubMed
35
Maharaj R, Mthembu DJ, Sharp BL. Impact of DDT re-introduction on malaria
transmission in KwaZulu-Natal. S Afr Med J 2005; 95: 871-874. PubMed
36
Craig MH, Kleinschmidt I, Le Sueur D, Sharp BL. Exploring 30 years of
malaria case data in KwaZulu-Natal, South Africa: part II—the impact of
non-climatic factors. Trop Med Int Health 2004; 9: 1258-1266. CrossRef|
PubMed
37
Craig MH, Kleinschmidt I, Nawn JB, Le Sueur D, Sharp BL. Exploring 30 years
of malaria case data in KwaZulu-Natal, South Africa: part I—the impact of
climatic factors. Trop Med Int Health 2004; 9: 1247-1257. CrossRef|
PubMed
38
Barnes KI, Durrheim DN, Little F, et al. Effect of artemether-lumefantrine
policy and improved vector control on malaria burden in KwaZulu-Natal, South
Africa. PLoS Med 2005; 2: e330. CrossRef|
PubMed
39
Sharp BL, Kleinschmidt I, Streat E, et al. Seven years of regional malaria
control collaboration—Mozambique, South Africa, and Swaziland. Am J Trop
Med Hyg 2007; 76: 42-47. PubMed
40
Bassat Q, Guinovart C, Sigauque B, et al. Malaria in rural Mozambique—Part
II: children admitted to hospital. Malar J 2008; 7: 37. CrossRef|
PubMed
41
Guinovart C, Bassat Q, Sigauque B, et al. Malaria in rural Mozambique—Part
I: children attending the outpatient clinic. Malar J 2008; 7: 36.
CrossRef | PubMed
42
Gerritsen AA, Kruger P, van der Loeff MF, Grobusch MP. Malaria incidence in
Limpopo Province, South Africa, 1998—2007. Malar J 2008; 7: 162.
CrossRef | PubMed
43
Steketee RW, Sipilanyambe N, Chimumbwa J, et al. National malaria control
and scaling up for impact: the Zambia experience through 2006. Am J Trop
Med Hyg 2008; 79: 45-52. PubMed
44Chizema-Kawesha E, Miller J, Steketee RW, Mukonka VM, Mukuka C. Scaling up
malaria control in Zambia: progress and impact 2005—2008. Am J Trop Med Hyg
(in press).
45
Chanda P, Hamainza B, Mulenga S, Chalwe V, Msiska C, Chizema-Kawesha E. Early
results of integrated malaria control and implications for the management of
fever in under-five children at a peripheral health facility: a case study
of Chongwe rural health centre in Zambia. Malar J 2009; 8: 49. CrossRef|
PubMed
46 Weekly
malaria surveillance in Zimbabwe. Wkly Epidemiol Rec 2003; 78: 398-400.
PubMed
47
Ceesay SJ, Casals-Pascual C, Erskine J, et al. Changes in malaria indices
between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008;
372: 1545-1554. Summary|
Full Text|
PDF(679KB) |
CrossRef|
PubMed
48
Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, et al. Evidence of decline of
malaria in the general hospital of Libreville, Gabon from 2000 to 2008. Malar
J 2009; 8: 300. CrossRef |
PubMed
49
Sarrassat S, Senghor P, Le Hesran JY. Trends in malaria morbidity following
the introduction of artesunate plus amodiaquine combination in M'lomp
village dispensary, south-western Senegal. Malar J 2008; 7: 215.
CrossRef | PubMed
50
Munier A, Diallo A, Marra A, et al. Evolution of malaria mortality and
morbidity after the emergence of chloroquine resistance in Niakhar, Senegal.
Malar J 2009; 8: 270. CrossRef|
PubMed
51
Orimadegun AE, Fawole O, Okereke JO, Akinbami FO, Sodeinde O. Increasing
burden of childhood severe malaria in a Nigerian tertiary hospital:
implication for control. J Trop Pediatr 2007; 53: 185-189. CrossRef|
PubMed
52
Muller O, Ye M, Louis VR, Sie A. Malaria in sub-Saharan Africa. Lancet
2009; 373: 122. Full Text|
PDF(91KB) |
CrossRef|
PubMed
53
Koudou BG, Tano Y, Keiser J, et al. Effect of agricultural activities on
prevalence rates, and clinical and presumptive malaria episodes in central
Côte d'Ivoire. Acta Trop 2009; 111: 268-274. CrossRef|
PubMed
54
Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based
combination therapy and insecticide-treated nets on malaria burden in
Zanzibar. PLoS Med 2007; 4: e309. CrossRef|
PubMed
55
Kleinschmidt I, Sharp B, Benavente LE, et al. Reduction in infection with Plasmodium
falciparum one year after the introduction of malaria control interventions
on Bioko Island, Equatorial Guinea. Am J Trop Med Hyg 2006; 74: 972-978.
PubMed
56
Kleinschmidt I, Torrez M, Schwabe C, et al. Factors influencing the
effectiveness of malaria control in Bioko Island, equatorial Guinea. Am J
Trop Med Hyg 2007; 76: 1027-1032. PubMed
57
Kleinschmidt I, Schwabe C, Benavente L, et al. Marked increase in child
survival after four years of intensive malaria control. Am J Trop Med Hyg
2009; 80: 882-888. PubMed
58
Teklehaimanot HD, Teklehaimanot A, Kiszewski A, Rampao HS, Sachs JD. Malaria
in Sao Tome and Principe: on the brink of elimination after three years of
effective antimalarial measures. Am J Trop Med Hyg 2009; 80: 133-140.
PubMed
59
Tseng LF, Chang WC, Ferreira MC, Wu CH, Rampao HS, Lien JC. Rapid control of
malaria by means of indoor residual spraying of alphacypermethrin in the
Democratic Republic of Sao Tome and Principe. Am J Trop Med Hyg 2008; 78:
248-250. PubMed
60
Negash K, Kebede A, Medhin A, et al. Malaria epidemics in the highlands of
Ethiopia. East Afr Med J 2005; 82: 186-192. PubMed
61
Lengeler C. Insecticide-treated bed nets for preventing malaria (Review). Cochrane
Database Syst Rev 2004; 2. CD000363. PubMed
62
Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC. Modelling the impact
of artemisinin combination therapy and long-acting treatments on malaria
transmission intensity. PLoS Med 2008; 5: e226. CrossRef|
PubMed
63
Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives
on malaria transmissibility. Lancet 1996; 347: 1654-1658. Summary|
CrossRef|
PubMed
64
Cairns M, Carneiro I, Milligan P, et al. Duration of protection against
malaria and anaemia provided by intermittent preventive treatment in infants
in Navrongo, Ghana. PLoS One 2008; 3: e2227. CrossRef|
PubMed
aSchool of Public Health and Health Services, George Washington University,
Washington, USA
bMoi Teaching and Referral Hospital, Eldoret, Kenya
cMalaria Control and Evaluation Partnership in Africa (MACEPA), PATH,
Ferney-Voltaire, France
dDepartment of Infectious and Tropical Diseases, London School of Hygiene and
Tropical Medicine, London, UK
Correspondence
to: Prof Brian Greenwood, Department of Infectious and Tropical Diseases,
London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E
7HT, UK
--
To subscribe or unsubscribe from these Child Survival Updates, pls contact
kidsurvival@gmail.com. If you unsubscribe, indicate from which E mail
address you are receving these updates.
When subscribing, write from your most permanent E-mail address, not always
that of your current employer.
Do not subscribe on behalf of friends or colleagues; forward updates to them
for their decision.
Those wishing to read only malaria updates should subscribe at
kidsurvivalmalaria@gmail.com
Those wishing to read only vaccination updates should subscribe at
kidsurvivalvaccination@gmail.com
READER COMMENTS
If you have a comment you want posted, send to rdavis@africamail.com
WEBPAGE
These updates are also available at www.childsurvival.net